Medicus Pharma launches at-the-market offering of up to 9.84M shares at $1.56, targeting $15.3M gross

Filed January 2, 2026 · ~2 min read

Key Changes

• high

  The company is offering up to 9,839,535 common shares at an assumed price of $1.56 per share, for gross proceeds of up to $15,349,674.

  The Offering verify on EDGAR →
• high

  This is a primary offering, so all proceeds go to the company, which intends to use them for product development and general corporate purposes.

  Use of Proceeds verify on EDGAR →
• high

  New investors will experience immediate dilution of approximately $1.00 per share, as the pro forma net tangible book value per share after the offering is only $0.56.

  Dilution verify on EDGAR →